16 Worcester Business Journal | Book of Lists 2026 | wbjournal.com
IT'S NOT PERSONAL, IT'S BUSINESS.
For industry expertise and personalized service contacts in New England:
Far Reaching Expertise, Well Within Reach
At Hilb Group, we harness the power of local connections and national resources to address
the unique challenges our clients and communities face. Our personalized service, combined
with innovative solutions, spans traditional offerings to specialized and custom programs in
insurance, benefits, retirement, and human resources. We help clients gain peace of mind by
protecting what matters most.
Joseph Padula
Commercial Lines
jpadula@hilbgroup.com
Rob Calise
Regional Leader
rcalise@hilbgroup.com
Local offices throughout New England, with locations nationwide | (800) 678-1700 | www.hilbgroup.com
Doug Mayhew
Personal Lines
dmayhew@hilbgroup.com
Thomas Allen
Employee Benefits
tallen@hilbgroup.com
WE GET IT.
Notable venture capital deals
Ranked by funding amount, then transaction date
Company
Industry/
products and services
Funding amount/
type/
transaction date Select investors Head of company
1
Neogenyx Fuels, an Ameresco Co.
Framingham
neogenyxfuels.com
Clean energy/
Biofuel & renewable natural
gas infrastructure projects
$300,000,000
Private equity
May 2026
HASI
Michael T. Bakas
CEO
2
VulcanForms
Devens
vulcanforms.com
Manufacturing/
Metal components
$220,000,000
Series D
Jan. 2026
1789 Capital, Eclipse, IEQ
Capital, Fontinalis Partners
Kevin Kassekert
CEO
3
Solmetex
Northborough
solmetex.com
Biotechnology/
Dental products
$200,000,000
Private equity
Oct. 2025
GTCR
Gene Dorff
CEO
4
Tortugas Neuroscience
Framingham
tortugasneuro.com
Biotechnology/
Novel medicines for
neurological conditions
$106,000,000
Series A
April 2026
AN Ventures, Cure Ventures,
The Column Group
Jeff Jonas
CEO
5
Lifeward (1)
Hudson
golifeward.com
Biotechnology/
Wearable robotic
exoskeleton
$27,000,000
Post-IPO equity
Jan. 2026
Oramed Pharmaceuticals
Mark Grant
president & CEO
6
Pulmatrix
Framingham
pulmatrix.com
Biotechnology/
Therapies for respiratory
diseases
$19,000,000
Post-IPO equity
March 2026
Rapha Capital Management
Peter Ludlum
interim CEO
7
DualBird
Westborough
dualbird.io
Information technology,
analytics/
Cloud-native acceleration for
data processes
$16,462,970
Series A
Nov. 2025
Lightspeed Venture
Partners, Bessemer Venture
Partners, Angular Ventures
Gilad Tal
co-founder & CEO
8
Curadel Surgical Innovations
Natick
curadelpharma.com
Biotechnology/
Contrast agents for image-
guided surgery
$14,479,902
Venture - series unknown
Oct. 2025
Undisclosed
John V. Frangioni
CEO
9
Precision Optics Corp.
Littleton
Aerospace & biotechnology/
Advanced optical and
medical instruments
$10,000,000
Post-IPO equity
March 2026
N/A
(2)
Joseph N. Forkey
president & CEO
Source: Crunchbase. Notes: Deals completed from Oct. 1, 2025 through June 15, 2026 were considered for this list. N/A=not available.
(1) Formerly ReWalk Robotics (2) Underwritten offering of 2,777,777 shares of common stock
-Compiled by: Stephanie R. Meagher, research@nebusinessmedia.com
Number
Money Date of
raised announced investors
$2 million June 26, 2017 1
$21 million Dec. 28, 2018 4
$5 million May 3, 2019 1
$77 million May 15, 2020 4
$250 million July 5, 2022 8
$220 million Jan. 30, 2026 5
VulcanForms'
capital raises
VulcanForms completed the
second-largest venture capital
financing in its history in January,
securing $220 million from lead
investors 1789 Capital and long-
time supporter Eclipse Ventures.
Source: Crunchbase
F O C U S B A N K I N G & F I N A N C E
